C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2006
11/22/2006	EP1723238A1 Modified oncolytic viruses
11/22/2006	EP1723237A2 Use of genes encoding outward potassium channels for modifying at least one phenotype linked to the size and organic acid content of at least one plant storage organ
11/22/2006	EP1723236A1 Method for the recombinant expression of an n-terminal fragment of hepatocyte growth factor
11/22/2006	EP1723178A2 Human g-protein chemokine receptor (ccr5) hdgnr10
11/22/2006	EP1723177A2 Rab9a, rab11a, and modulators thereof related to infectious disease
11/22/2006	EP1723176A1 Means for a quantitative detection of cytochrome c
11/22/2006	EP1723175A1 Galanin receptors and brain injury
11/22/2006	EP1723174A1 A novel modulator of glucocorticoid receptor activities
11/22/2006	EP1723173A1 Il-4/il-13 sepecific polypetides and therapeutic uses thereof
11/22/2006	EP1723172A1 Erythropoietin liquid formulation
11/22/2006	EP1723171A1 Method for the purification of an n-terminal fragment of hepatocyte growth factor
11/22/2006	EP1723170A1 A canine vaccine for protection against ehrlichiosis
11/22/2006	EP1723169A1 Novel tat complexes, and vaccines comprising them
11/22/2006	EP1723168A2 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays
11/22/2006	EP1723139A1 Cell targeting conjugates
11/22/2006	EP1722834A1 Matrix comprising naturally-occurring crosslinked protein backbone
11/22/2006	EP1722819A2 Method for solubilising peptide mixtures
11/22/2006	EP1722818A2 Photoreactive compound specifically binding to calcium binding proteins
11/22/2006	EP1722814A2 Infectious bursal disease virus antigenic isolates and vaccines
11/22/2006	EP1722808A2 Egf receptor epitode peptides and uses thereof
11/22/2006	EP1722765A2 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone
11/22/2006	EP1627064A4 Flowering inhibition
11/22/2006	EP1626981A4 Dipeptidyl-peptidase protected proteins
11/22/2006	EP1601382A4 Phospholipid scramblase 3
11/22/2006	EP1558746A4 Nucleic acids encoding duramycin
11/22/2006	EP1556694A4 Method of isolation and self-assembly of small protein particles from blood and other biological materials
11/22/2006	EP1531692B1 Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants
11/22/2006	EP1511770B1 Glycoprotein vi-fc fusion protein for the treatment of vascular diseases
11/22/2006	EP1480998B1 Intermediates and methods for making heptapeptide oxytocin analogues
11/22/2006	EP1373571B1 Functional surface display of polypeptides
11/22/2006	EP1309342B1 Production of a chimeric human papillomavirus
11/22/2006	EP1294757B1 Glucagon-like peptide-1 analogs
11/22/2006	EP1294386B1 Synthetic oxygen carriers made from cross-linked modified human or porcine haemoglobin, method for a preparation thereof from purified material and use thereof
11/22/2006	EP1283668B1 Nucleic acids that control plant development
11/22/2006	EP1266025B1 Protein scaffolds for antibody mimics and other binding proteins
11/22/2006	EP1263781B1 Viral antigen and vaccine against isav (infectious salmon anaemia virus)
11/22/2006	EP1214098B1 Capsid-modified recombinant adenovirus and methods of use
11/22/2006	EP1194777B1 Methods and compositions relating to pancreatic islet and beta-cell dysfunction
11/22/2006	EP1173465B1 Novel human voltage-gated potassium channel
11/22/2006	EP1163522B1 Method for detecting msrv-1 induced superantigen activity in a biological sample
11/22/2006	EP1146899B1 Methods of using neurotrophin 3 (nt-3) for the treatment of gastrointestinal hypomotility disorders
11/22/2006	EP1078054B1 Monomeric mp52/gdf-5 with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
11/22/2006	EP1071774B1 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
11/22/2006	EP1054895B1 Novel peptide diagnostic reagent and kit for detection of rickettsiosis
11/22/2006	EP1053309B1 Compositions and methods for wound healing
11/22/2006	EP1040120B1 Antifungal and antibacterial peptides
11/22/2006	EP1037603B1 Membrane virus host range mutations and their uses as vaccine substrates
11/22/2006	EP1015570B1 Fibrin microbeads and uses thereof
11/22/2006	EP1000168B1 A swine hepatitis e virus and uses thereof
11/22/2006	EP1000158B1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
11/22/2006	EP0890105B1 Methods related to Alzheimer's disease for diagnosis, manufacture of medicaments and screening of substances and beta-amyloid related peptides
11/22/2006	EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006	EP0783003B1 G-CSF TPO fusion proteins
11/22/2006	CN1867673A NELL-1 enhanced bone mineralization
11/22/2006	CN1867671A Compositions and methods for prognosis and therapy of liver cancer
11/22/2006	CN1867670A Methods of degrading dsRNA and synthesizing RNA
11/22/2006	CN1867667A Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics
11/22/2006	CN1867666A Control of es cell self-renewal and lineage specification, and medium therefor
11/22/2006	CN1867588A Product comprising a c4bp core protein and a monomeric antigen, and its use
11/22/2006	CN1867582A Process for preparing an alpha-1-antitrypsin solution
11/22/2006	CN1867581A Il－21衍生物 Il-21 derivatives
11/22/2006	CN1867362A Cancer gene therapeutic drug
11/22/2006	CN1867361A Cancer gene therapeutic drug
11/22/2006	CN1867354A Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/22/2006	CN1867352A Therapeutic uses of chemokine variants
11/22/2006	CN1867350A Recombinant lubricin molecules and uses thereof
11/22/2006	CN1865441A Human source nuclein for taking part in microfilament assembly and regulation, and its preparation and application method
11/22/2006	CN1865440A Novel pathogenetic gene mutation of hypertrophic cardiomyopathy and use thereof
11/22/2006	CN1865284A Receptor of the edb-fibronectin domains
11/22/2006	CN1865283A Solid phase polypeptide synthesis preparation method for salcatonin
11/22/2006	CN1285612C Animal collagens and gelatins
11/22/2006	CN1285611C Synthetic process for alkaline phosphatase marked free thyroid hormone
11/22/2006	CN1285610C Human liver regeneration promoting factor derivative and its expression
11/22/2006	CN1285609C Recombinant N protein antigen and purification method for transmissible gastroenteritis of swine
11/22/2006	CN1285608C Parainfluenza virus glycoproteins and vaccines
11/22/2006	CN1285381C Chemokine mutants in treatment of multiple sclerosis
11/21/2006	US7138571 Inbred corn line SE8505
11/21/2006	US7138569 Nucleic acids encoding pseudomonas hop proteins and use thereof
11/21/2006	US7138568 Expression vector coding insecticidal protein for use in the transformation and generation of moth resistant leafy plants
11/21/2006	US7138566 Controlling expression of plant growth regulators and producing disease, stress and drought resistant plants
11/21/2006	US7138564 Isolated Amaranthus agglutinin gene and uses thereof
11/21/2006	US7138563 Gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene
11/21/2006	US7138562 Expression vector for use in generating genetically engineering animal for use as tool in generating preferential proteins
11/21/2006	US7138515 Translational activity-promoting higher-order structure
11/21/2006	US7138513 Genes encoding for genetic stability, gene expression and folding proteins
11/21/2006	US7138512 Gene SHINC-2 and diagnostic and therapeutic uses thereof
11/21/2006	US7138511 Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
11/21/2006	US7138510 Cloning sequencing and characterization of two cell death genes and uses therefor
11/21/2006	US7138508 Inhibitor protein of the wnt signal pathway
11/21/2006	US7138501 Antibodies that immunospecifically bind BLyS
11/21/2006	US7138500 Antibodies to human 4-1BB
11/21/2006	US7138498 DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of
11/21/2006	US7138494 Comprises amino acid transport protein (ASC-1) for regulating NMDA-type glutamic acid receptor; treatment of nervous system disorders; antiproliferative agents; gene expression inhibition
11/21/2006	US7138492 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
11/21/2006	US7138491 3S-(2-Arg-Pro-Ala-Lys)-1,2,3,4,-tetrahydro-beta-carboline-3-carboxylic acid and 3S-(2-Pro-Ala-Lys)-1,2,3,4,-tetrahydro-beta-carboline-3-carboxylic acid
11/21/2006	US7138489 Method for producing a modified peptide
11/21/2006	US7138488 Viricides
11/21/2006	US7138486 Insulinotropic hormone derivatives and uses thereof
11/21/2006	US7138381 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/2006	US7138380 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease

1 ... 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 ... 2916